Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer
暂无分享,去创建一个
Shelly C. Lu | J. Bruix | D. Xirodimas | F. Lopitz-Otsoa | L. Boix | M. Varela-Rey | David Fernández-Ramos | X. Buqué | P. Aspichueta | J. Mato | A. Cano | A. Castro | Dimitris P. Xirodimas | N. Beraza | Pablo Fernández-Tussy | E. Villa | Lucía Barbier-Torres | J. L. García-Rodríguez | V. G. Juan | T. C. Delgado | M. Martínez‐Chantar | Imanol Zubiete‐Franco | I. Fernández-Domínguez | Xabier Buqué | F. Lopitz‐Otsoa | Itziar Fernández-Domínguez
[1] Bill Bynum,et al. Lancet , 2015, The Lancet.
[2] E. Petricoin,et al. Cancer metabolism and mass spectrometry-based proteomics. , 2015, Cancer letters.
[3] Shelly C. Lu,et al. Excess S‐adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis , 2013, Hepatology.
[4] A. Paiardini,et al. Glycine consumption and mitochondrial serine hydroxymethyltransferase in cancer cells: the heme connection. , 2013, Medical hypotheses.
[5] D. Hardie,et al. LKB1 and AMPK and the cancer-metabolism link - ten years after , 2013, BMC Biology.
[6] Shelly C. Lu,et al. Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1. , 2012, Gastroenterology.
[7] Yi Sun,et al. The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth. , 2012, Cancer research.
[8] Shelly C. Lu,et al. Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation , 2012, Hepatology.
[9] Anindya Dutta,et al. NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. , 2010, Cancer research.
[10] Stephanie Roessler,et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. , 2010, Cancer research.
[11] Shelly C. Lu,et al. Liver‐specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice , 2010, Hepatology.
[12] Shelly C. Lu,et al. Activation of LKB1‐Akt pathway independent of phosphoinositide 3‐kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis , 2010, Hepatology.
[13] Francis J Giles,et al. Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia. , 2010, Blood.
[14] Geng-Hung Liu,et al. Regulation of nucleolar signalling to p53 through NEDDylation of L11 , 2009, EMBO reports.
[15] Frans M van der Kloet,et al. Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. , 2009, Journal of proteome research.
[16] Xin Lin,et al. The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation , 2009, Science.
[17] R. Shaw,et al. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.
[18] W. Zou,et al. Over‐expression of pemt2 into rat hepatoma cells contributes to the mitochondrial apoptotic pathway , 2009, IUBMB life.
[19] Amanda Doucette,et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer , 2009, Nature.
[20] N. Hay,et al. Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. , 2009, Seminars in cancer biology.
[21] D. Xirodimas,et al. Novel substrates and functions for the ubiquitin-like molecule NEDD8. , 2008, Biochemical Society transactions.
[22] Shelly C. Lu,et al. Loss of the glycine N‐methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice , 2007, Hepatology.
[23] H. Clevers,et al. Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer , 2007, Oncogene.
[24] E. Gottlieb,et al. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.
[25] Ji Luo,et al. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.
[26] D. Assimos,et al. Glycolate and glyoxylate metabolism in HepG2 cells. , 2004, American journal of physiology. Cell physiology.
[27] D. Lane,et al. Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity , 2004, Cell.
[28] J. Klco,et al. pVHL Modification by NEDD8 Is Required for Fibronectin Matrix Assembly and Suppression of Tumor Development , 2004, Molecular and Cellular Biology.
[29] E. Albi,et al. Chromatin sphingomyelin changes in cell proliferation and/or apoptosis induced by ciprofibrate , 2003, Journal of cellular physiology.
[30] M. Papotti,et al. Expression of Phosphatidylethanolamine N-Methyltransferase in Human Hepatocellular Carcinomas , 2003, Oncology.
[31] R. Hay,et al. NEDP1, a Highly Conserved Cysteine Protease That deNEDDylates Cullins* , 2003, Journal of Biological Chemistry.
[32] S. Thorgeirsson,et al. Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.
[33] Y. Nishizuka. Protein kinase C and lipid signaling for sustained cellular responses , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] D. Vance,et al. Phosphatidylcholine metabolism in rat liver after partial hepatectomy. Evidence for increased activity and amount of CTP:phosphocholine cytidylyltransferase. , 1991, The Biochemical journal.
[35] Eyal Gottlieb,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[36] D. Wallace,et al. Mitochondria and cancer: Warburg addressed. , 2005, Cold Spring Harbor symposia on quantitative biology.
[37] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[38] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.